SLC25A12 and neoplasm: Compared with tumors derived from the above four groups, AGC1-OE or MKRN1-KD plus AGC1-KD CRC cells showed significantly increased tumor growth, prolonged overall survival rate, and decreased apoptosis rates (Fig. 3M and O).